Office of the Assistant Secretary for Health, Washington, DC.
Millennium Health LLC, San Diego, California.
JAMA. 2020 Oct 27;324(16):1674-1677. doi: 10.1001/jama.2020.17694.
This substance use epidemiology study uses a commercial urine drug testing (UDT) service’s data to compare UDT results for cocaine, fentanyl, heroin, and methamphetamine before vs after US declaration of coronavirus disease 2019 (COVID-19) as a national emergency among patients diagnosed with or at risk of substance use disorders.
这项物质使用流行病学研究利用商业尿液药物检测(UDT)服务的数据,比较了美国宣布 2019 年冠状病毒病(COVID-19)为全国性紧急状态前后,诊断患有或有物质使用障碍风险的患者的可卡因、芬太尼、海洛因和甲基苯丙胺的 UDT 结果。